Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck.
In This Article:
Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen next.
Terms and Privacy Policy